CAMK2G and breast carcinoma: Taken together, our data indicate that T286 phosphorylation of CaMKII controls breast cancer cell migration and invasion, and highlights the potential therapeutic implications of preventing CaMKII phosphorylation at T286 as a new treatment for controlling breast cancer cell metastasis.